Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
Үндсэн зохиолчид: | Xu, S, Scott, C, Coleman, RL, Tuomilehto, J, Holman, RR |
---|---|
Формат: | Conference item |
Хэл сонгох: | English |
Хэвлэсэн: |
Springer Nature
2019
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
-н: Xu, S, зэрэг
Хэвлэсэн: (2021) -
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
-н: Wamil, M, зэрэг
Хэвлэсэн: (2020) -
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
-н: Leal, J, зэрэг
Хэвлэсэн: (2022) -
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
-н: Holman, R, зэрэг
Хэвлэсэн: (2017) -
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
-н: Currie, G, зэрэг
Хэвлэсэн: (2017)